Legal & General Group
BDSX icon

Legal & General Group’s Biodesix BDSX Stock Holding History

Legal & General Group’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-65
Closed -$2K – 3533
2022
Q1 		$2K Hold
65
– – ﹤0.01% 3547
2021
Q4 		$7K Hold
65
– – ﹤0.01% 3512
2021
Q3 		$11K Hold
65
– – ﹤0.01% 3426
2021
Q2 		$17K Buy
65
+50
+333% +$15.7K ﹤0.01% 3341
2021
Q1 		$6K Hold
15
– – ﹤0.01% 3459
2020
Q4 		$6K Buy
+15
New +$4.67K ﹤0.01% 3418

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Legal & General Group's BDSX Position: Q2 2022 in Review

Legal & General Group sold out of Biodesix (BDSX) in Q2 2022, closing a stake of 65 shares — an estimated $2K sold.

Legal & General Group first reported a position in BDSX in Q4 2020 and held it in 6 quarters. The position peaked at $17K in Q2 2021. 36 funds tracked by Wall St. Rank hold BDSX as of Q2 2022.

  • Legal & General Group reported no remaining Biodesix position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 65 Biodesix shares in Q2 2022, an estimated $2K.
  • Legal & General Group first reported a position in Biodesix in Q4 2020 and held it in 6 quarters.
  • Legal & General Group's Biodesix position peaked at $17K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Biodesix as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.